Covid-19 Long-term Revalidation Follow-up

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2020-05-07

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this monocentric, prospective and descriptive trial we want to evaluate the long-term consequences for patients treated for Covid-19. Covid patients who were hospitalized for min. 5 days either in a Covid-19 department or in intensive care unit will be followed-up for 8 weeks after hospital discharge. This is done via an innovative electronic platform in the home environment (UZA@home). On the one hand the quality of life, rehabilitation and reintegration of the patient will be evaluated and on the other hand the patient will be screened for various psychosocial aspects such as anxiety, depression and post-traumatic stress syndrome.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-term Effects of COVID-19: a Comparative Cohort Study

NCT05002205

Covid19

UNKNOWN

Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands

NCT04488562

COVID-19 Pulmonary Fibrosis

COMPLETED

The COVID HOME Study: Prospective Cohort Study of Non-hospitalised COVID-19 Patients

NCT06282627

COVID-19 Post-COVID-19 Syndrome

COMPLETED

poSt Covid-19 Infection centraL sENsitisaTion

NCT04703452

Covid19

UNKNOWN

Risk Factors Worsening COVID19 for Out-patient With Home Monitoring

NCT04380662

Covid19

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

25 post ICU-patients

patients who were hospitalized in an intensive care unit

Intervention Type DIAGNOSTIC_TEST

25 post non-ICU patients

patients who were not hospitalized in an intensive care unit

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males and females
* Adult age
* Hospitalization with proven Covid-19 infection with a minimum stay of 5 days
* Signed Informed Consent

Exclusion Criteria

* The patient does not have a smartphone or computer with internet connection.The patient is not sufficiently skilled in entering data via a digital interface. This degree of skill is estimated by the research doctor or nurse.
* Patient in a palliative setting (DNR 2 or higher outside of COVID condition
* The patient does not speak the Dutch language

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No